Doris L. Lefkowitz

1.2k total citations
37 papers, 936 citations indexed

About

Doris L. Lefkowitz is a scholar working on Immunology, Pharmacology and Molecular Biology. According to data from OpenAlex, Doris L. Lefkowitz has authored 37 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Doris L. Lefkowitz's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (15 papers), Immune Response and Inflammation (7 papers) and Immune cells in cancer (7 papers). Doris L. Lefkowitz is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (15 papers), Immune Response and Inflammation (7 papers) and Immune cells in cancer (7 papers). Doris L. Lefkowitz collaborates with scholars based in United States and Belgium. Doris L. Lefkowitz's co-authors include Stanley S. Lefkowitz, Alex Bollen, Nicole Moguilevsky, John A. Lincoln, Monique P. Gelderman, Steven R. Fuhrmann, S. Margolin, K. C. Mills, David L. Morgan and Johannes Everse and has published in prestigious journals such as Free Radical Biology and Medicine, Methods in enzymology on CD-ROM/Methods in enzymology and The Journal of Infectious Diseases.

In The Last Decade

Doris L. Lefkowitz

37 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris L. Lefkowitz United States 17 408 181 150 101 100 37 936
Stanley S. Lefkowitz United States 19 474 1.2× 273 1.5× 191 1.3× 118 1.2× 105 1.1× 64 1.2k
Els L.R. Swennen Netherlands 11 272 0.7× 311 1.7× 114 0.8× 108 1.1× 106 1.1× 11 1.3k
David B. Drath United States 16 333 0.8× 395 2.2× 190 1.3× 52 0.5× 106 1.1× 29 1.2k
Naoko Matsunaga Japan 12 605 1.5× 409 2.3× 105 0.7× 98 1.0× 108 1.1× 28 1.4k
Kenji Suga Japan 18 814 2.0× 444 2.5× 86 0.6× 79 0.8× 107 1.1× 46 2.3k
Martin D. Lehner Germany 19 519 1.3× 320 1.8× 202 1.3× 68 0.7× 173 1.7× 42 1.2k
Hiromi Ota Japan 6 222 0.5× 207 1.1× 124 0.8× 31 0.3× 78 0.8× 12 861
Sumiko Sasagawa Japan 11 261 0.6× 251 1.4× 235 1.6× 44 0.4× 197 2.0× 26 1.2k
David A. Mark United States 16 532 1.3× 176 1.0× 365 2.4× 40 0.4× 103 1.0× 25 1.2k
Rafael Fernandes Zanin Brazil 22 236 0.6× 396 2.2× 71 0.5× 71 0.7× 64 0.6× 40 1.2k

Countries citing papers authored by Doris L. Lefkowitz

Since Specialization
Citations

This map shows the geographic impact of Doris L. Lefkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris L. Lefkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris L. Lefkowitz more than expected).

Fields of papers citing papers by Doris L. Lefkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris L. Lefkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris L. Lefkowitz. The network helps show where Doris L. Lefkowitz may publish in the future.

Co-authorship network of co-authors of Doris L. Lefkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Doris L. Lefkowitz. A scholar is included among the top collaborators of Doris L. Lefkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris L. Lefkowitz. Doris L. Lefkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lefkowitz, Doris L. & Stanley S. Lefkowitz. (2005). Fascioscapulohumeral muscular dystrophy: A progressive degenerative disease that responds to diltiazem. Medical Hypotheses. 65(4). 716–721. 12 indexed citations
2.
Lincoln, John A., Stanley S. Lefkowitz, Alex Bollen, et al.. (2002). Alveolar Macrophage Activation by Myeloperoxidase. American Journal of Respiratory Cell and Molecular Biology. 26(6). 716–722. 64 indexed citations
3.
Lefkowitz, Doris L., John A. Lincoln, Robert C. Allen, et al.. (2000). The Endothelium and Cytokine Secretion: The Role of Peroxidases as Immunoregulators. Cellular Immunology. 202(1). 23–30. 38 indexed citations
4.
Lefkowitz, Doris L., et al.. (2000). Effects of a glyconutrient on macrophage functions. International Journal of Immunopharmacology. 22(4). 299–308. 7 indexed citations
5.
Lefkowitz, Doris L., et al.. (2000). Inhibition of influenza virus replication by cocaine. International Journal of Immunopharmacology. 22(2). 105–111. 2 indexed citations
6.
Lefkowitz, Doris L., Monique P. Gelderman, Steven R. Fuhrmann, et al.. (1999). Neutrophilic Myeloperoxidase–Macrophage Interactions Perpetuate Chronic Inflammation Associated with Experimental Arthritis. Clinical Immunology. 91(2). 145–155. 78 indexed citations
7.
Lincoln, John A., et al.. (1999). Enzymatically Inactive Eosinophil Peroxidase Inhibits Proinflammatory Cytokine Transcription and Secretion by Macrophages. Cellular Immunology. 196(1). 23–33. 3 indexed citations
8.
Lefkowitz, Doris L., et al.. (1998). Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone. International Journal of Immunopharmacology. 20(12). 685–695. 74 indexed citations
9.
10.
Lefkowitz, Doris L., et al.. (1997). Upregulation of phagocytosis and candidicidal activity of macrophages exposed to the immunostimulant, acemannan. International Journal of Immunopharmacology. 19(2). 75–82. 43 indexed citations
11.
Lefkowitz, Stanley S., et al.. (1997). Cocaine Inhibits Production of Murine Hepatitis Virus by Peritoneal Macrophages In Vitro. Experimental Biology and Medicine. 215(1). 87–93. 8 indexed citations
12.
Lefkowitz, Stanley S., et al.. (1996). Alteration of Macrophage Functions by Cocaine. Advances in experimental medicine and biology. 402. 135–144. 2 indexed citations
13.
Lefkowitz, Doris L., K. C. Mills, Stanley S. Lefkowitz, Alex Bollen, & Nicole Moguilevsky. (1995). Neutrophil-macrophage Interaction: a paradigm for chronic inflammation. Medical Hypotheses. 44(1). 58–62. 17 indexed citations
14.
Lefkowitz, Stanley S., et al.. (1994). The effects of cocaine and its metabolites on the production of reactive oxygen and reactive nitrogen intermediates. Life Sciences. 55(22). PL439–PL444. 15 indexed citations
15.
Lefkowitz, Stanley S., et al.. (1993). Cocaine Alters the Respiratory Burst and Phagocytic Activity of Murine Macrophages. Clinical Immunology and Immunopathology. 69(2). 161–166. 13 indexed citations
16.
Lefkowitz, Doris L., et al.. (1993). Regulation of macrophage function by human recombinant myeloperoxidase. Immunology Letters. 36(1). 43–49. 35 indexed citations
17.
Lefkowitz, Stanley S., et al.. (1993). Effects of Cocaine on the Respiratory Burst of Murine Macrophages. Advances in experimental medicine and biology. 335. 135–142. 6 indexed citations
18.
Lefkowitz, Stanley S., et al.. (1993). Cocaine reduces macrophage killing by inhibiting reactive nitrogen intermediates. International Journal of Immunopharmacology. 15(6). 717–721. 15 indexed citations
19.
Lefkowitz, Doris L., et al.. (1990). Induction of tumor necrosis factor and cytotoxicity by macrophages exposed to lactoperoxidase and microperoxidase. Life Sciences. 47(8). 703–709. 9 indexed citations
20.
Lefkowitz, Doris L., et al.. (1989). Peroxidases Enhance Macrophage-Mediated Cytotoxicity Via Induction of Tumor Necrosis Factor. Experimental Biology and Medicine. 190(2). 144–149. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley S. Lefkowitz Breakdown of academic impact, for papers by Els L.R. Swennen Breakdown of academic impact, for papers by David B. Drath Breakdown of academic impact, for papers by Naoko Matsunaga Breakdown of academic impact, for papers by Kenji Suga Breakdown of academic impact, for papers by Martin D. Lehner Breakdown of academic impact, for papers by Hiromi Ota Breakdown of academic impact, for papers by Sumiko Sasagawa Breakdown of academic impact, for papers by David A. Mark Breakdown of academic impact, for papers by Rafael Fernandes Zanin
Rankless by CCL
2026